ABSCI CORP Repayments of Long-Term Debt
ABSCI CORP (ABSI) reported Repayments of Long-Term Debt of $723.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-11
- ABSCI CORP repayments of long-term debt for the quarter ending 2026-06-30 was $263.00K, a 75.67% decline year-over-year.
- ABSCI CORP repayments of long-term debt for the quarter ending 2026-03-31 was $460.00K, a 39.63% decline year-over-year.
- ABSCI CORP repayments of long-term debt for the quarter ending 2025-12-31 was $498.00K, a 44.61% decline year-over-year.
- ABSCI CORP repayments of long-term debt for the quarter ending 2025-09-30 was $776.00K, a 4.90% decline year-over-year.
- ABSCI CORP repayments of long-term debt for fiscal 2025 was $3.12M, a 8.00% decline from fiscal 2024.
- ABSCI CORP repayments of long-term debt for fiscal 2024 was $3.39M, a 12.48% increase from fiscal 2023.
- ABSCI CORP repayments of long-term debt for fiscal 2023 was $3.01M, a 35.24% decline from fiscal 2022.
- ABSCI CORP repayments of long-term debt for fiscal 2022 was $4.65M, a 190.69% increase from fiscal 2021.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $263.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $723.00K 10-Q · filed 2026-08-11 | $1.22M derived: sum of 3 quarters · filed 2026-08-11 | $2.00M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $460.00K 10-Q · filed 2026-05-07 | $958.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.73M derived: sum of 3 quarters · filed 2026-05-07 | $2.81M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $498.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $1.27M derived: sum of 2 quarters · filed 2026-03-24 | $2.35M derived: sum of 3 quarters · filed 2026-08-11 | $3.12M 10-K · filed 2026-03-24 |
| 2025-09-30 | $776.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.86M derived: sum of 2 quarters · filed 2026-08-11 | $2.62M 10-Q · filed 2025-11-12 | $3.52M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $1.84M 10-Q · filed 2026-08-11 | $2.74M derived: sum of 3 quarters · filed 2026-08-11 | $3.56M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $762.00K 10-Q · filed 2026-05-07 | $1.66M derived: sum of 2 quarters · filed 2026-05-07 | $2.48M derived: sum of 3 quarters · filed 2026-05-07 | $3.28M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $899.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $1.72M derived: sum of 2 quarters · filed 2026-03-24 | $2.52M derived: sum of 3 quarters · filed 2026-03-24 | $3.39M 10-K · filed 2026-03-24 |
| 2024-09-30 | $816.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.62M derived: sum of 2 quarters · filed 2025-11-12 | $2.49M 10-Q · filed 2025-11-12 | $3.33M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $801.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.67M 10-Q · filed 2025-08-12 | $2.52M derived: sum of 3 quarters · filed 2025-08-12 | $3.28M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $872.00K 10-Q · filed 2025-05-13 | $1.72M derived: sum of 2 quarters · filed 2025-05-13 | $2.48M derived: sum of 3 quarters · filed 2025-05-13 | $3.22M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $844.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $1.60M derived: sum of 2 quarters · filed 2025-03-18 | $2.35M derived: sum of 3 quarters · filed 2025-03-18 | $3.01M 10-K · filed 2025-03-18 |
| 2023-09-30 | $761.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.51M derived: sum of 2 quarters · filed 2024-11-12 | $2.17M 10-Q · filed 2024-11-12 | $2.73M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $745.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.41M 10-Q · filed 2024-08-14 | $1.97M derived: sum of 3 quarters · filed 2024-08-14 | $2.36M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $662.00K 10-Q · filed 2024-05-14 | $1.23M derived: sum of 2 quarters · filed 2024-05-14 | $1.61M derived: sum of 3 quarters · filed 2024-05-14 | $4.71M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $565.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $953.00K derived: sum of 2 quarters · filed 2024-03-21 | $4.05M derived: sum of 3 quarters · filed 2024-03-21 | $4.65M 10-K · filed 2024-03-21 |
| 2022-09-30 | $388.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $3.49M derived: sum of 2 quarters · filed 2023-11-14 | $4.09M 10-Q · filed 2023-11-14 | $4.69M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $3.70M 10-Q · filed 2023-08-14 | $4.30M derived: sum of 3 quarters · filed 2023-08-14 | $5.16M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $600.00K 10-Q · filed 2023-05-15 | $1.20M derived: sum of 2 quarters · filed 2023-05-15 | $2.06M derived: sum of 3 quarters · filed 2023-05-15 | $2.20M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.46M derived: sum of 2 quarters · filed 2023-03-30 | $1.60M derived: sum of 3 quarters · filed 2023-03-30 | $1.60M 10-K · filed 2023-03-30 |
| 2021-09-30 | $861.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.00M derived: sum of 2 quarters · filed 2022-11-09 | $1.00M 10-Q · filed 2022-11-09 | $1.00M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $139.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $139.00K 10-Q · filed 2022-08-11 | $139.00K derived: sum of 3 quarters · filed 2022-08-11 | $139.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-11 | $0.00 derived: sum of 2 quarters · filed 2022-05-11 | $0.00 derived: sum of 3 quarters · filed 2022-05-11 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $0.00 derived: sum of 2 quarters · filed 2022-03-22 | $500.00K 10-K · filed 2022-03-22 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $500.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $500.00K 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |